Iba57 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| IBA57 Protein |
|---|
| Protein Name | Iron-Sulfur Cluster Assembly Factor IBA57 |
| Gene | IBA57 |
| UniProt | Q9H1K0 |
| Molecular Weight | 40 kDa |
| Subcellular Localization | Mitochondria |
| Protein Family | Fe-S cluster assembly factor family |
IBA57 (Iron-Sulfur Cluster Assembly Factor) is a mitochondrial protein essential for the maturation of [4Fe-4S] cluster-containing proteins. It plays a critical role in iron-sulfur cluster biogenesis, which is fundamental to mitochondrial electron transport chain function and cellular respiration. Mutations in IBA57 cause hereditary spastic paraplegia (SPG74) and severe neurodevelopmental disorders[1].
IBA57 contains several key structural features:
- C-terminal Domain: Required for complex formation with ISCA1/ISCA2 proteins
- Fe-S Binding Motifs: Conserved cysteine residues for Fe-S cluster coordination
- Dimerization Interface: Forms functional homodimers in mitochondria
IBA57 is crucial for multiple cellular processes:
- Fe-S Cluster Biogenesis: IBA57 forms a complex with ISCA1 and ISCA2 to catalyze the final step of [4Fe-4S] cluster assembly on target proteins[2]
- Mitochondrial Respiration: Required for proper function of Complex I (NADH:ubiquinone oxidoreductase), Complex II (succinate dehydrogenase), and Complex III (cytochrome bc1 complex)
- Iron Homeostasis: Regulates mitochondrial iron metabolism and prevents iron overload
- DNA Repair: Essential for the function of DNA repair enzymes including DNA glycosylases
The IBA57-ISCA1-ISCA2 complex operates as a specialized Fe-S cluster assembly module:
- Cluster Transfer: The complex receives pre-assembled [2Fe-2S] clusters from scaffold proteins
- Cluster Conversion: Converts [2Fe-2S] to [4Fe-4S] clusters through currently undefined mechanisms
- Target Loading: Directly transfers [4Fe-4S] clusters to recipient proteins including:
- Respiratory chain complexes (NDUFS1, NDUFS2, SDHB)
- DNA repair enzymes (UNG2, SMUG1)
- Metabolic enzymes (aconitase, fumarase)
Recessive mutations in IBA57 cause a pure form of hereditary spastic paraplegia with:
- Adult onset (typically 20-40 years)
- Progressive lower limb spasticity
- Mild to moderate paraparesis
- Impaired mitochondrial Fe-S protein maturation in patient fibroblasts[1]
Severe de novo mutations cause an early-onset disorder characterized by:
- Profound developmental delay
- Seizures
- Dysmorphic features
- Multiple congenital anomalies
- Early childhood mortality due to mitochondrial dysfunction
The link between IBA57 dysfunction and neurodegeneration involves:
- Mitochondrial Energy Failure: Reduced Complex I/II/III activity leads to ATP depletion
- Oxidative Stress: Impaired Fe-S enzymes increase reactive oxygen species
- Axonal Degeneration: Mitochondrial dysfunction preferentially affects long motor axons
Currently, no disease-modifying therapies exist for IBA57-related disorders. Potential therapeutic strategies include:
- Metabolic Support: CoQ10 supplementation and B-vitamin complexes
- Mitochondrial Biogenesis Agents: PGC-1α agonists under development
- Antioxidant Therapy: Mitochondrial-targeted antioxidants (MitoQ)
- Gene Therapy: AAV-mediated IBA57 delivery being explored in preclinical models
Key research priorities include:
- Understanding the molecular mechanism of [2Fe-2S] to [4Fe-4S] conversion
- Developing biomarkers for disease progression
- Creating patient-derived cellular models
- Screening for small molecules that enhance IBA57 function
The study of Iba57 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Torraco A, et al. (2017). Novel mutations in IBA57 cause hereditary spastic paraplegia. Brain. PMID:28087769
- Guiducci L, et al. (2019). The IBA57-ISCA1-ISCA2 complex in iron-sulfur cluster assembly. J Mol Biol. PMID:31150732
- Beilschmidt LK, et al. (2017). Mitochondrial iron-sulfur protein biogenesis and human disease. Biochimie. PMID:28757454
- Lill R, et al. (2012). Iron-sulfur protein biogenesis in eukaryotes. Biochim Biophys Acta. PMID:22506986
- Stehling O, et al. (2014). Human NFS1 undergoes maturation in the mitochondrial matrix. Nat Commun. PMID:24819424
- Senkevich K, et al. (2020). Clinical spectrum of IBA57-related disorders. Neurology Genetics. PMID:32051589